New guidance for chronic primary pain

In-depth

New guidance for chronic primary pain

In In-depth

New NICE guidance for chronic primary pain highlights the importance of individualised treatment

People with chronic primary pain should be offered a variety of treatments to help manage their condition and not automatically be started on commonly used drug treatments for pain, according to new National Institute for Health and Care Excellence (NICE) guidance on the assessment and management of chronic pain. 

Collaborative care

In the UK, the prevalence of chronic pain – defined as pain that lasts for more than three months – is uncertain, but could affect between one-third and one-half of the population.

The new guidance, published on 7 April 2021, emphasises the importance of putting patients at the centre of their own care and the need for shared decision making. It highlights the responsibility of healthcare professionals to gain an understanding of how a person’s life affects their pain and vice versa, including work and leisure time, relationships and sleep. A care and support plan should be developed based on the effects of pain on the individual’s day-to-day activities, as well as their preferences, abilities and goals, the guideline explains. Being honest about the uncertainty of the prognosis is also important, it adds.

Dr Paul Chrisp, director of the Centre for Guidelines at NICE, commented: “Achieving an understanding of how pain is affecting a person’s life and those around them, and knowing what is important to the person, is the first step in developing an effective care and support plan that recognises and treats a person’s pain as valid and unique to them.”

Alternative action

The guideline makes recommendations for effective interventions for chronic primary pain including exercise programmes, cognitive behavioural therapy (CBT) or acceptance and commitment therapy (ACT) and acupuncture within certain clearly defined parameters. 

The use of, or reliance on, drug treatments such as paracetamol, NSAIDs, benzodiazepines or opioids, is discouraged due to a lack of evidence that they improve quality of life, pain or psychological distress, and the risk of causing harm, such as addiction. However, antidepressants may be considered for those aged over 18 years to help with quality of life, pain, sleep and psychological distress, even in the absence of a diagnosis of depression.

“This guideline will provide more consistency in treatment and support on the NHS for people experiencing chronic pain,” said Lucy Ryan, a patient representative on the guideline committee. “I am pleased that it has highlighted the potential risks of some of the drugs used to treat chronic primary pain as I feel people are sometimes not made aware of these.”

Record my learning outcomes

In-depth

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off
In-depth

RoE 2021 winners revealed

The RoE Awards 2021 winners were announced at a glittering awards ceremony on 21 September. So who took home the top prizes?

3 Min Article

bookmark_icon_off
In-depth

Get POP ready

How will women and community pharmacy benefit from the contraceptive POM to P switch?

4 Min Article

bookmark_icon_off
In-depth

Exclusive: 60% of pharmacies running out of masks

Sixty-two per cent of pharmacists report they won’t have enough face masks to last the next seven days.

2 Min Article

bookmark_icon_off
In-depth

Reclassifying oral contraceptives

The POM to P switch of an oral contraceptive pill could open doors to ease access and improve self care for women.

1 Min Article

bookmark_icon_off
In-depth

Covid booster plans

England’s community pharmacies will play an even bigger role in the Covid jab booster drive than in the current vaccination programme.

1 Min Article

bookmark_icon_off
In-depth

Fibre under the microscope

A recent study says fibre offers vital protection against potentially fatal health conditions. How can pharmacy teams help?

4 Min Article

Recommended Learning

Sponsored education

Covid-19 and mental health

Viatris has created this short video based on a publication reviewing global research into the potential impact of the Covid-19 pandemic on mental health. It identifies six areas where psychiatrists can play a role in supporting people's mental health through these difficult times.

4 Min Module

Bayer Business Programme

Retail ready: Building confidence in retail skills - Module

How to make the most of technology and the commercial opportunites it offers

10 Min Module

bookmark_icon_off
Sponsored education

Fungal Nail Roundup

Complete this short interactive module to refresh your knowledge on identifying and treating fungal nail infections, and discover more about a product you can recommend to customers.

5 Min Module

bookmark_icon_off
Videos

Treating acid reflux and heartburn in the pharmacy

Understand how omeprazole 20mg works to treat heartburn and acid reflux symptoms

2 Min Module

bookmark_icon_off
Videos

Advising on thrush treatment

This video looks at the distinctive benefits of different combination products and how to find the right treatment option for your customer.

7 Min Module

bookmark_icon_off
Sponsored education

Managing dry eye and blepharitis

Discover the link between dry eye and blepharitis and learn how to help customers effectively manage these conditions.

10 Min Module